CORRECTING and REPLACING: Mainstay Medical International plc: Standard form for notification of major holdings
February 20 2018 - 12:32PM
Business Wire
Regulatory News:
This replaces the announcement made at 18:49 pm on 19th February
2018 due to the following corrections:
The date at the end, and in sections 5 and 6 of this form have
been amended from 14 February 2018 to 15 February 2018.
Standard Form TR-1
Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer
and to the Central Bank of Ireland)i
1. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attachedii
:
Mainstay Medical International plc
2. Reason for the notification (please tick the appropriate
box or boxes):
[x] An acquisition or disposal of voting
rights
[ ] An acquisition or disposal of
financial instruments
[x] An event changing the breakdown of
voting rights
[ ] Other (please specify)iii:
3. Details of person subject to the notification
obligationiv
: Name:
Fountain Healthcare Partners Fund 1,
L.P.
City and country of registered office (if applicable): N/A
Two Dockland Central, 4th floor, Guild St
IFSC, Dublin
4. Full name of shareholder(s) (if different from 3.)v: N/A
5. Date on which the threshold was crossed or
reachedvi
: 15 February 2018
6. Date on which issuer
notified: 15 February 2018
7. Threshold(s) that is/are
crossed or reached: Below 12%
8. Total positions of
person(s) subject to the notification obligation:
% of voting rights attached to shares (total of 9.A) % of voting
rights through financial instruments(total of 9.B.1 + 9.B.2)
Total of both in % (9.A + 9.B) Total number of voting rights
of issuervii Resulting situation on the date on which threshold was
crossed or reached 10.7% N/A 10.7% 935,220 Position of previous
notification (if applicable) 12% N/a 12%
9. Notified details of the resulting situation on the date on
which the threshold was crossed or reachedviii:
A: Voting rights attached to shares Class/type
ofshares
ISIN code (if possible)
Number of voting rightsix
% of voting
rights
Direct
Indirect
Direct
Indirect
935,220 N/A 10.7% N/A
SUBTOTAL A 935,220
10.7%
B 1: Financial Instruments according to
Regulation 17(1)(a) of the Regulations Type of financial
instrument Expirationdatex
Exercise/ Conversion Periodxi
Number of voting
rights that may be acquired if the instrument is
exercised/converted. % of voting rights
SUBTOTAL B.1
B 2: Financial Instruments with similar economic
effect according to Regulation 17(1)(b) of the Regulations
Type of financial instrument Expirationdatex
Exercise/ Conversion Period xi
Physical or
cash settlementxii
Number of voting rights %
of voting rights
SUBTOTAL B.2 10.
Information in relation to the person subject to the notification
obligation (please tick the applicable box)
:
[x] Person subject to the notification
obligation is not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding directly or
indirectly an interest in the (underlying) issuer.xiii
[ ] Full chain of
controlled undertakings through which the voting rights and/or
thefinancial instruments are effectively held starting with
the ultimate controlling natural person or legal
entityxiv:
Namexv
% of voting rights if it equals or is higher than
the notifiable threshold % of voting rights through
financial instruments if it equals or is higher than the notifiable
threshold Total of both if it equals or is higher than the
notifiable threshold
11. In case of proxy
voting: [name of the proxy holder] will cease to hold [% and
number] voting rights as of [date]
N/A
12. Additional informationxvi
:
N/A
Done at Dublin on 15 February 2018.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180220006238/en/
Mainstay Medical International plc